National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Cerebral Astrocytoma/Malignant Glioma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 02/21/2006



General Information About Childhood Cerebral Astrocytoma






Stages of Childhood Cerebral Astrocytoma






Recurrent Childhood Cerebral Astrocytoma






Treatment Option Overview







Treatment Options for Childhood Cerebral Astrocytoma






Get More Information From NCI






Changes to This Summary (2/21/2006)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

NIH Calendar of Events

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
HPV Vaccines for Cervical Cancer
Treatment Options for Childhood Cerebral Astrocytoma

Low-Grade Childhood Cerebral Astrocytoma
High-Grade Childhood Cerebral Astrocytoma
Recurrent Childhood Cerebral Astrocytoma



Low-Grade Childhood Cerebral Astrocytoma

Initial treatment for low grade cerebral astrocytoma depends on the location of the tumor. When the tumor is completely removed by surgery, more treatment may not be needed. The child is then closely observed for symptoms to appear or change. This is called watchful waiting. When the tumor is located deep inside the brain, surgery may not be possible. Biopsy followed by chemotherapy or radiation therapy may be used instead.

When cancer cells remain after surgery, treatment depends on the location of the remaining cancer cells and the age of the child. Treatment may include the following:

  • Watchful waiting.
  • Another surgery to remove the tumor.
  • Radiation therapy.
  • Chemotherapy.

One of the treatments being studied in clinical trials for low grade childhood cerebral astrocytoma is combination chemotherapy.

Information about this and other ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood low-grade cerebral astrocytoma.

High-Grade Childhood Cerebral Astrocytoma

Standard treatment of high grade childhood cerebral astrocytoma may include surgery followed by chemotherapy and radiation therapy.

Some of the treatments being studied in clinical trials for high grade childhood cerebral astrocytoma include the following:

  • A clinical trial of surgery followed by chemotherapy to delay or reduce the use of radiation therapy for children younger than 3 years of age.
  • A clinical trial of surgery followed by chemotherapy with or without radiation therapy.
  • A clinical trial of surgery followed by chemotherapy during and after radiation therapy.

Information about these and other ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood high-grade cerebral astrocytoma.

Recurrent Childhood Cerebral Astrocytoma

Standard treatment of recurrent low grade childhood cerebral astrocytoma may include the following:

Some of the treatments being studied in clinical trials for recurrent low grade childhood cerebral astrocytoma include new ways of giving radiation.

Standard treatment of recurrent high grade childhood cerebral astrocytoma may include biopsy or surgery.

Some of the treatments being studied in clinical trials for recurrent high grade childhood cerebral astrocytoma include the following:

Information about these and other ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent childhood cerebral astrocytoma.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov